Gilder Gagnon Howe & CO LLC Sangamo Therapeutics, Inc Transaction History

Gilder Gagnon Howe & CO LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$9.51 - $16.6 $265,157 - $462,841	-27,882 Closed	0 $0
Q2 2018 Jul 31, 2018	SELL	$13.9 - $19.8 $472 - $673	-34 Reduced 0.12%	27,882 $396,000
Q1 2018 Apr 30, 2018	SELL	$16.7 - $26.35 $1,269 - $2,002	-76 Reduced 0.27%	27,916 $530,000
Q4 2017 Jan 31, 2018	SELL	$11.6 - $17.35 $33,999 - $50,852	-2,931 Reduced 9.48%	27,992 $459,000
Q3 2017 Nov 06, 2017	BUY	$8.4 - $15.0 $259,753 - $463,845	30,923	30,923 $464,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $335M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.